Guillermo studied Biology and obtained his PhD (1997) at the School of Biology of Universidad Complutense de Madrid. After defending his PhD, he got an EMBO long-term fellowship to work in Philip Cohen’s laboratory at the MRC Protein Phosphorylation Unit (Dundee, Scotland) on a project aimed at studying the regulation and of the Rho-activated protein kinase (ROCK). In 1999 he got a position as Assistant Teacher at the School of Chemistry of Universidad Complutense de Madrid and since 2003 he is an Associated Professor of the Department of Biochemistry and Molecular Biology. In 2001 he started a line of research aimed at investigating the mechanisms underlying cannabinoid antitumoral action as well as at optimizing the potential clinical utilization of these agents in cancer therapies.
Mar Lorente obtained her PhD at the Centro de Investigaciones Biológicas (CSIC) of Madrid and after that, she joined our laboratory with a Juan de la Cierva postdoctoral fellowship. Now, Mar works as a postdoctoral researcher and she focuses her job in the study of the mechanisms associated to the resistance of the tumoral cells to the treatment by cannabinoids in order to improve the therapies against brain tumors and, particularly, gliomas.
Israel graduated in Biology at Universidad Complutense de Madrid in 2012. In 2014, he was awarded with a PFIS predoctoral grant by the Hospital Clinico San Carlos. His PhD project is focused on studying the role of the Midkine/ALK axis in gliomas with the aim to design new therapeutic strategies for the treatment of these tumors.
Alba graduated in Biochemistry at Universidad Complutense de Madrid in 2014. In this same year, she joined our group to perform her Bachelor’s Thesis. She later did a Master in Biochemistry, Molecular Biology and Biomedicine at Universidad Complutense de Madrid and in 2015 she started her PhD, which is based in the dual role of TRIB3 pseudokinase in breast cancer development and progression.
Estibaliz got her Bachelor’s Degree in Biochemistry and Molecular Biology at the University of the Basque Country. She performed her Bachelor’s Thesis in Rosa Barrio´s lab at CICbioGUNE. The aim of the project was to study the role of the transcription factor SALL1 in the Townes-Brocks Syndrome. After this period, she moved to Madrid and she got a Master’s Degree in Genetics and Molecular Biology at Universidad Complutense de Madrid. Estibaliz joined our lab in 2017 to do her Master´s Thesis. Now, she is a PhD student and her work focusses on the role of autophagy regulating AMBRA1 protein in tumor development and progression.
Jack graduated with a Master’s in Biological and Medicinal Chemistry from the University of East Anglia (UEA), UK in 2016. During his studies at the University of East Anglia, Jack worked at Massachusetts General Hospital, Boston, USA for the summer of 2015 studying renal physiology. Following his graduation, he worked at Queen Mary University, London in the Centre for Endocrinology before joining us in Madrid in 2017. Jack’s PhD project forms part of the Tribbles Research and Innovation Network – TRAIN, funded by the EU under the Marie Sklodowska Curie Innovative Training Network. His thesis surrounds the effect of the pseudokinase Tribbles 3 on cancer progression in the context of prostate cancer.
Kunzangla completed her Bachelor’s Degree in Biotechnology, Chemistry and Zoology from Christ University Bangalore, India (2010-2013) and her Master’s Degree in Biotechnology from Pondicherry University, India (2014-2016). During her Master, she had the opportunity to work in different ends of Molecular biology spectrum including protein-protein interaction and protein functional studies. She joined the lab in 2017 as part of the Tribbles Research and Innovation Network – TRAIN and now she is working to define the role of TRIB3 in development of cancer.
“I am excited to continue exploring and growing here at Universidad Complutense de Madrid” – Kunzangla Bhutia.
Nélida graduated in Biology at Universidad de León in 2001 and finished her post graduate studies in “Molecular Biology and Biotechnology”, obtaining the DEA at the University of León in 2005. Her professional career began in the department of Cell Biology of the company BIOMAR Microbial Technologies located in León, where she worked for 8 years (2001-2008). In February 2008 she joined the company Projech, Science to Technology, S.L with a Torres Quevedo technologist contract. From January 2011 to May 2014, with a contract associated to the Subprogram Technical support staff- MICINN, she specialized in Mass-spectrometry techniques at the Protein Unit of the Biochemistry Service of the Hospital Universitario Ramón y Cajal (Madrid). She became a member of our group in 2016, where she takes part in several projects as Superior Technician.